These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 17158672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aspartyl-tRNA synthetase is the target of peptide nucleotide antibiotic Microcin C.
    Metlitskaya A, Kazakov T, Kommer A, Pavlova O, Praetorius-Ibba M, Ibba M, Krasheninnikov I, Kolb V, Khmel I, Severinov K.
    J Biol Chem; 2006 Jun 30; 281(26):18033-42. PubMed ID: 16574659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Microcin C: biosynthesis, mode of action, and potential as a lead in antibiotics development.
    Vondenhoff GH, Van Aerschot A.
    Nucleosides Nucleotides Nucleic Acids; 2011 Jun 30; 30(7-8):465-74. PubMed ID: 21888539
    [Abstract] [Full Text] [Related]

  • 5. MccE provides resistance to protein synthesis inhibitor microcin C by acetylating the processed form of the antibiotic.
    Novikova M, Kazakov T, Vondenhoff GH, Semenova E, Rozenski J, Metlytskaya A, Zukher I, Tikhonov A, Van Aerschot A, Severinov K.
    J Biol Chem; 2010 Apr 23; 285(17):12662-9. PubMed ID: 20159968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The mechanism of microcin C resistance provided by the MccF peptidase.
    Tikhonov A, Kazakov T, Semenova E, Serebryakova M, Vondenhoff G, Van Aerschot A, Reader JS, Govorun VM, Severinov K.
    J Biol Chem; 2010 Dec 03; 285(49):37944-52. PubMed ID: 20876530
    [Abstract] [Full Text] [Related]

  • 10. Extended targeting potential and improved synthesis of Microcin C analogs as antibacterials.
    Vondenhoff GH, Dubiley S, Severinov K, Lescrinier E, Rozenski J, Van Aerschot A.
    Bioorg Med Chem; 2011 Sep 15; 19(18):5462-7. PubMed ID: 21855353
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enzymatic Synthesis and Functional Characterization of Bioactive Microcin C-Like Compounds with Altered Peptide Sequence and Length.
    Bantysh O, Serebryakova M, Zukher I, Kulikovsky A, Tsibulskaya D, Dubiley S, Severinov K.
    J Bacteriol; 2015 Oct 15; 197(19):3133-41. PubMed ID: 26195597
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Histidine-Triad Hydrolases Provide Resistance to Peptide-Nucleotide Antibiotics.
    Yagmurov E, Tsibulskaya D, Livenskyi A, Serebryakova M, Wolf YI, Borukhov S, Severinov K, Dubiley S.
    mBio; 2020 Apr 07; 11(2):. PubMed ID: 32265328
    [Abstract] [Full Text] [Related]

  • 20. Architecture of Microcin B17 Synthetase: An Octameric Protein Complex Converting a Ribosomally Synthesized Peptide into a DNA Gyrase Poison.
    Ghilarov D, Stevenson CEM, Travin DY, Piskunova J, Serebryakova M, Maxwell A, Lawson DM, Severinov K.
    Mol Cell; 2019 Feb 21; 73(4):749-762.e5. PubMed ID: 30661981
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.